Bioelectronics (BIEL) ready for blast-off!:
1) Golden Cross and Blue Skies Breakout Imminent! The 50 dma is .0001, 200 dma is .0002, yearly high is .0005.
2) Profitabity: BIEL has cut costs to the bone, such that about $1.5 million annual revenue should make them profitable - they are close, if not already there.
3) Their Actipatch/RecoveryRx pain relief medical device sells on Amazon and has numerous international distributors.
4) Actipatch/RecoveryRx is highly effective (often 5 star rated) and should be a Standard of Care for every adult and pet on the planet.
5) They have 5 FDA clearances and a huge new utility patent (pending).
6) Insurance coverage is expanding.
7) 911 Market Maker signal a few days ago.
8) #1 on the Breakout Boards last Sunday (and #8 on Most Read Boards with over 220,000 reads).
9) Daily volume steadily increasing.